Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Champions Oncology (CSBR) Shares Repurchased (2023)

Champions Oncology has reported Shares Repurchased over the past 3 years, most recently at $32000.0 for Q4 2023.

  • Quarterly results put Shares Repurchased at $32000.0 for Q4 2023, changed N/A from a year ago — trailing twelve months through Jul 2024 was $32000.0 (down 95.27% YoY), and the annual figure for FY2024 was $634000.0, up 756.76%.
  • Shares Repurchased for Q4 2023 was $32000.0 at Champions Oncology, down from $602000.0 in the prior quarter.
  • Over the last five years, Shares Repurchased for CSBR hit a ceiling of $602000.0 in Q3 2023 and a floor of $32000.0 in Q4 2023.